SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-17-129234
Filing Date
2017-04-20
Accepted
2017-04-19 21:55:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d358883dsc13da.htm SC 13D/A 26955
  Complete submission text file 0001193125-17-129234.txt   28437
Mailing Address 222 THIRD STREET CAMBRIDGE MA 02142
Business Address 222 THIRD STREET CAMBRIDGE MA 02142 781-365-2596
CoLucid Pharmaceuticals, Inc. (Subject) CIK: 0001348649 (see all company filings)

IRS No.: 203419541 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88836 | Film No.: 17771237
SIC: 2834 Pharmaceutical Preparations

Mailing Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900
Business Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900 45 8824 8824
Novo A/S (Filed by) CIK: 0001388325 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13D/A